Skip to main content

Research Repository

Advanced Search

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

Jones, Roy W.; Soininen, Hilkka; Hager, Klaus; Aarsland, Dag; Passmore, Peter; Murthy, Anita; Zhang, Richard; Bahra, Ranbir

Authors

Roy W. Jones

Hilkka Soininen

Klaus Hager

Dag Aarsland

Peter Passmore

Anita Murthy

Richard Zhang

Ranbir Bahra



Abstract

Objectives: To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). Methods: Patients with mild to moderate AD from 14 European centres were randomised to receive open-label donepezil (up to 10 mg once daily) or galantamine (up to 12 mg twice daily) for 12 weeks, according to the approved product labelling. Physicians and caregivers completed questionnaires rating satisfaction with treatment/ease of use in daily practice. Secondary assessments were the ADAS-cog, the MMSE, and the DAD scale to assess ADL. Tolerability was evaluated by reporting adverse events (AEs). Results: Both physicians and caregivers reported significantly greater overall satisfaction/ease of use for donepezil (n = 64) compared with galantamine (n = 56) at weeks 4, 12, and endpoint (week 12 LOCF; all p-values

Citation

Soininen, H., Jones, R. W., Hager, K., Aarsland, D., Passmore, P., Murthy, A., …Bahra, R. (2004). A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. International Journal of Geriatric Psychiatry, 19(1), 58-67. https://doi.org/10.1002/gps.1038

Journal Article Type Article
Publication Date Jan 1, 2004
Journal International Journal of Geriatric Psychiatry
Print ISSN 0885-6230
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 19
Issue 1
Pages 58-67
DOI https://doi.org/10.1002/gps.1038
Keywords donepezil, galantamine, Alzheimer's disease, dementia
Public URL https://uwe-repository.worktribe.com/output/1063764
Publisher URL http://dx.doi.org/10.1002/gps.1038

Downloadable Citations